FDA-approved drugs as PIM-1 kinase inhibitors: A drug repurposed approach for cancer therapy
Aanchal Rathi, Saba Noor, Md Nayab Sulaimani, Shahbaz Ahmed, Aaliya Taiyab, Mohamed F. Alajmi, Faez Iqbal Khan, Md. Imtaiyaz Hassan, Mohammad Mahfuzul Haque
Topics & Concepts
DrugCancer drugsPharmacologyCancer therapyDrug repositioningApproved drugMedicineCancerInternal medicineCancer Mechanisms and Therapy